Filing Flows › Comparisons › SOLV vs RMD
Solventum vs ResMed: SOLV and RMD compared
Solventum is the larger company: $1.9B of revenue in its latest quarter (Q3 2026) against $1.4B for ResMed (Q1 FY27). ResMed is growing faster (+6% against -7% a year earlier). ResMed is more profitable, with an operating margin of 32.0% against 3.5%.
Where the money goes: SOLV and RMD
Solventum (SOLV) · Q3 2026
Solventum, Q3 2026: revenue $1.9B (-7% year over year), operating margin 3.5%, net loss $12.0M, operating cash flow $177M. The chart follows the revenue to costs, profit and cash.
ResMed (RMD) · Q1 FY27
ResMed, Q1 FY27: revenue $1.4B (+6% year over year), operating margin 32.0%, net earnings $418M, operating cash flow $422M. The chart follows the revenue to costs, profit and cash.
| Solventum (SOLV) | ResMed (RMD) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q1 FY27 |
| Revenue | $1.9B | $1.4B |
| Revenue growth, Y/Y | -7% | +6% |
| Gross margin | — | 61.5% |
| Operating margin | 3.5% | 32.0% |
| Net earnings | −$12.0M | $418M |
| Net margin | -0.6% | 29.6% |
| Operating cash flow | $177M | $422M |
| Free cash flow | $97.0M | $374M |
| Market value | $15.6B | $33.5B |
| P/E | 99.4× | 21.3× |
| Analysts’ mean target | $96.92 | $264.33 |
Where the revenue comes from
Solventum
- Product: $1.4B (73%)
- Software and rentals: $518M (27%)
ResMed
- Total Sleep and Breathing Health: $1.3B (89%)
- Residential Care Software: $155M (11%)
Questions
Which is bigger, Solventum or ResMed?
Solventum is the larger company: $1.9B of revenue in its latest quarter (Q3 2026) against $1.4B for ResMed (Q1 FY27).
Is Solventum or ResMed growing faster?
ResMed is growing faster (+6% against -7% a year earlier).
Which is more profitable, Solventum or ResMed?
ResMed is more profitable, with an operating margin of 32.0% against 3.5%.
More: Solventum earnings · how Solventum makes money · ResMed earnings · how ResMed makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Oct 30, 2026). Fiscal quarters can end on different dates. Not investment advice.